Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight.

Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon) and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite.

The company is headquartered in Natick, Massachusetts.